Are you our next guest expert? Upcoming virtual networking events and industry news for August.

As we settle into the 'new normal', we're all becoming more comfortable with the shift from in-person to online engagement and there have been some surprising benefits to a digital experience (no more flight reschedules and early morning airport runs, to name a few!).

TrialStat recently launched our “Ask Us Anything” virtual networking meetups and a new series of Webinars featuring clinical research specialists ready to answer your questions and we've been thrilled with the positive feedback so far.

Links to two of our recent event recordings can be found below.

We'd love to have you join us from the comfort of your home for our next casual meet up (register for an upcoming session).

If you have a clinical research question, or just miss the post-conference networking experience and meeting new industry contacts, our “Ask Us Anything” meetups are casual, held after hours, and have a new guest expert each time.

Maybe you might even want to propose a topic or be a guest expert yourself - we'd love to hear from you!

Chris Hamelin
Business Unit Head
TrialStat Solutions Inc.

Ask Us Anything In Clinical Trials - Pharmacovigilance

This is our second meeting in our ongoing series titled “Ask us Anything – in Clincal Trials”. In this meeting we were fortunate to host our guests from JSS Research and their Pharmacovigilance team. We had a great time discussing the importance of Pharmacovigilance within the clinical trial process.

If you’d like to catch the entire meeting just click the video down below!

TrialStat Webinar: Leveraging The Power of Interoperable eClinical Technology to Run Efficient Clinical Trials

On July 15th TrialStat together with our partners Fujifilm TeraMedica and SimpleTrials held a joint webinar called Leveraging the Power of Interoperable eClinical Technology To Run Efficient Clinical Trials.

We had a fantastic time producing and hosting this webinar taking advantage of some new video technology we developed to help produce a more exciting experience for our guests.

When you have a moment you can watch the webinar and hear from Christopher Kata, Chris Hamelin, Heather Williams, Bill Lynch and Jon Cecchettini as we discuss the power of a truly unified and interoperable eClinical platform.

Albireo Launches Expanded Access Program for Odevixibat for Patients in the U.S., Canada, Australia and Europe

"BOSTON, July 20, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the launch of an Expanded Access Program (EAP) for investigational lead product candidate odevixibat, a highly potent and selective inhibitor of the ileal bile acid transporter (IBAT), for patients with progressive familial intrahepatic cholestasis (PFIC) in the U.S., Canada, Australia and Europe."